tiprankstipranks
Advertisement
Advertisement

ONCY Stock Latest News

ONCY Upcoming Earnings Report: What to Expect?
Pre-EarningsONCY Upcoming Earnings Report: What to Expect?
19d ago
ONCY
Oncolytics Biotech Faces Nasdaq Minimum Bid Price Noncompliance
PremiumCompany Announcements
Oncolytics Biotech Faces Nasdaq Minimum Bid Price Noncompliance
24d ago
8K
ONCY
Oncolytics Biotech gains FDA Fast Track for pelareorep
PremiumCompany Announcements
Oncolytics Biotech gains FDA Fast Track for pelareorep
28d ago
8K
ONCY
Oncolytics announces FDA Fast Track designation for pelareorep
PremiumThe Fly
Oncolytics announces FDA Fast Track designation for pelareorep
28d ago
ONCY
Oncolytics Biotech advances REO 033 colorectal cancer program
PremiumCompany Announcements
Oncolytics Biotech advances REO 033 colorectal cancer program
1M ago
8K
ONCY
Oncolytics provides clinical, regulatory update on REO 033
PremiumThe FlyOncolytics provides clinical, regulatory update on REO 033
1M ago
ONCY
Oncolytics Biotech Secures New Pelareorep Manufacturing Patent
Premium
Company Announcements
Oncolytics Biotech Secures New Pelareorep Manufacturing Patent
2M ago
8K
ONCY
Oncolytics secures new patent for pelareorep manufacturing
Premium
The Fly
Oncolytics secures new patent for pelareorep manufacturing
2M ago
ONCY
Oncolytics promotes John McAdory to COO
PremiumThe Fly
Oncolytics promotes John McAdory to COO
3M ago
CGON
ONCY
Oncolytics Biotech Strengthens Leadership with New COO, Director
PremiumCompany Announcements
Oncolytics Biotech Strengthens Leadership with New COO, Director
3M ago
8K
ONCY
Oncolytics Highlights Pelareorep-RAS Combo Preclinical Cancer Results
PremiumCompany Announcements
Oncolytics Highlights Pelareorep-RAS Combo Preclinical Cancer Results
3M ago
8K
ONCY
Oncolytics announces initial data from pelareorep combination study
PremiumThe Fly
Oncolytics announces initial data from pelareorep combination study
3M ago
ONCY
Oncolytics Biotech to present data at ASCO 2026 on pelareorep
PremiumThe FlyOncolytics Biotech to present data at ASCO 2026 on pelareorep
3M ago
ONCY
Oncolytics Highlights Pelareorep Immune Activation Data at ASCO
Premium
Company Announcements
Oncolytics Highlights Pelareorep Immune Activation Data at ASCO
3M ago
8K
ONCY
Jason McCarthy Reiterates Buy Rating and Maintains $3 Price Target on Advancing Pelareorep Oncology Pipeline
Premium
Ratings
Jason McCarthy Reiterates Buy Rating and Maintains $3 Price Target on Advancing Pelareorep Oncology Pipeline
3M ago
ONCY
Oncolytics Biotech Highlights Strong Pelareorep Data in Colorectal Cancer
PremiumCompany Announcements
Oncolytics Biotech Highlights Strong Pelareorep Data in Colorectal Cancer
4M ago
8K
ONCY
Oncolytics says in alignment with FDA following pelareorep Type C meeting
PremiumThe Fly
Oncolytics says in alignment with FDA following pelareorep Type C meeting
4M ago
ONCY
Oncolytics Biotech Aligns with FDA on Pelareorep Trial
PremiumCompany Announcements
Oncolytics Biotech Aligns with FDA on Pelareorep Trial
4M ago
8K
ONCY
Oncolytics Biotech: Buy Rating on Pelareorep’s Advancing Registrational Path and Oncolytic Virus Sector Tailwinds
PremiumRatings
Oncolytics Biotech: Buy Rating on Pelareorep’s Advancing Registrational Path and Oncolytic Virus Sector Tailwinds
4M ago
ONCY
Oncolytics price target lowered to $5 from $7 at Lake Street
PremiumThe FlyOncolytics price target lowered to $5 from $7 at Lake Street
4M ago
ONCY
Oncolytics Biotech Establishes $75 Million ATM Offering
Premium
Company Announcements
Oncolytics Biotech Establishes $75 Million ATM Offering
4M ago
8K
ONCY
Oncolytics Plans FDA Meeting for Pelareorep SCAC Study
Premium
Company Announcements
Oncolytics Plans FDA Meeting for Pelareorep SCAC Study
4M ago
8K
ONCY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >